Table: begin end state 1 15 cytoplasmic 16 39 transmembrane 40 63 non-cytoplasmic 64 82 transmembrane 83 92 cytoplasmic 93 110 transmembrane 111 115 non-cytoplasmic 116 139 transmembrane 140 147 cytoplasmic 148 166 transmembrane 167 197 non-cytoplasmic 198 217 transmembrane 218 245 cytoplasmic 246 267 transmembrane 268 275 non-cytoplasmic 276 294 transmembrane 295 297 cytoplasmic 298 319 transmembrane 320 324 non-cytoplasmic 325 345 transmembrane 346 362 cytoplasmic
Input: >AZOBR_RS06955 FitnessBrowser__azobra:AZOBR_RS06955 MTLLRLEPRGEASRAMVYATPLLAVALTLASGFLLFWAMGFDPVKALHAFFIAPLLSLRG LGELAVKATPLVLCAIGLAIGFRANVWNIGAEGQLTLGAITGGGLALAFYGEGGWWLLPL MIVAGMAGGALWAAIPAFLRVRFNASEILTSLMLNYVALHLLNYLMHGPYRDPDGFAFPE SRLFEADAVLPLLVAGTRVHLGSLFALLAVAAGWFLMARTFIGFQIKVIGLTPTAAGYAG FNQKKIIWLTLLLSGALAGLAGLGEVAGPIGQMNPTISPGYGYTAIIVAFLGRLHPVGIL LAGFLMALSFIGGEAAQIALGLPKAITGVFQGMLLFFLLATDVLIRYRVRFGAKGIVGRA AA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server